Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data (2014)
- Authors:
- Autor USP: SQUIRE, JEREMY ANDREW - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.cancergen.2014.09.003
- Subjects: NEOPLASIAS PROSTÁTICAS (GENÉTICA;PATOLOGIA); MAPEAMENTO CROMOSSÔMICO; BIOINFORMÁTICA; GENÔMICA
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2014
- Source:
- Título do periódico: Cancer Genetics
- ISSN: 2210-7762
- Volume/Número/Paginação/Ano: v. 207, n. 10-12, p. 474-488, 2014
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc-nd
-
ABNT
WILLIAMS, Julia L e GREER, Peter A e SQUIRE, Jeremy Andrew. Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data. Cancer Genetics, v. 207, n. 10-12, p. 474-488, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.cancergen.2014.09.003. Acesso em: 11 jun. 2024. -
APA
Williams, J. L., Greer, P. A., & Squire, J. A. (2014). Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data. Cancer Genetics, 207( 10-12), 474-488. doi:10.1016/j.cancergen.2014.09.003 -
NLM
Williams JL, Greer PA, Squire JA. Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data [Internet]. Cancer Genetics. 2014 ; 207( 10-12): 474-488.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.cancergen.2014.09.003 -
Vancouver
Williams JL, Greer PA, Squire JA. Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data [Internet]. Cancer Genetics. 2014 ; 207( 10-12): 474-488.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.cancergen.2014.09.003 - Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
- Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies
- In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in sity hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
- STAT1-associated intratumoural TH1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancer
- Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections
- In silico shows that PTEN loss and AR overexpression are associated with increased CD8+ T-cell and Treg density and earlier disease recurrence in prostate cancer
Informações sobre o DOI: 10.1016/j.cancergen.2014.09.003 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
